GSA Capital Partners »

Travere Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $452k 59k 7.71
2020-12-31 $1.1M 42k 27.24

More positions owned by GSA Capital Partners

Progressive Corporation (PGR)
Amazon (AMZN)
Root Cl A New (ROOT)
Meta Platforms Cl A (META)
Monster Beverage Corp (MNST)
UGI Corporation (UGI)
Magnite Ord (MGNI)
John B. Sanfilippo & Son (JBSS)
Dt Midstream Common Stock (DTM)
Weis Markets (WMK)
Apa Corporation (APA)
Appfolio Com Cl A (APPF)
Hims & Hers Health Com Cl A (HIMS)
Zoetis Cl A (ZTS)
Vital Farms (VITL)

View all positions for GSA Capital Partners

Top funds holding Travere Therapeutics

BlackRock
Armistice Capital
Deep Track Capital
State Street Corporation
Vanguard Group
Macquarie Group
Morgan Stanley
Rock Springs Capital Management
Renaissance Technologies
Deutsche Bank Aktiengesellschaft
Pictet Asset Management Holding SA
Millennium Management
Kynam Capital Management
D. E. Shaw & Co
Emerald Advisers

View all funds holding Travere Therapeutics